DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.
about
DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier stateCharacterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigensAdvances in immunomodulating therapy of HBV infectionImmunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection modeCationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccineDevelopment of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope proteinDNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccinationStrategies for improving responses to DNA vaccinesCpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young miceDNA vaccines for viral diseases.Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune responseCpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum.Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responsesImmunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virusBoosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid.Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections.Technological advances to increase immunogenicity of DNA vaccines.Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmidsBicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunityGene therapy of liver diseases.Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patientsSimian immunodeficiency virus DNA vaccine trial in macaques.Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery.Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBVVaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania majorHumoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeysRoute and method of delivery of DNA vaccine influence immune responses in mice and non-human primatesDNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc.Characterization and expression of e2 glycoprotein of classical Swine Fever virus in a eukaryotic expression system.Therapeutic vaccination in chronic hepatitis B virus carriers.Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model.Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules.DNA vaccines for emerging infectious diseases: what if?
P2860
Q24607288-35DE0F86-6557-428C-B0E3-8397614F290DQ24673500-75E0DA3E-14AF-44BE-B5CD-20467EC3846BQ24810147-F3460062-C55A-4F64-8639-D86F4838E751Q27480864-79D99399-CDCA-4657-8404-0B8BD5883BDCQ28656316-C3FF40C4-E14B-490A-816E-F9DACDC2F03FQ28731516-1B96638D-5CDC-457C-A678-F43BAB1A0E5AQ31028199-908238EF-F4C5-478B-A65C-036D299DC4C6Q33525552-89D543A3-8DFC-4C0E-8722-1DEB991F68C9Q33540135-B408AD80-09D8-418C-A723-8109EE78D4F3Q33597242-715C2905-07F4-487A-96B8-15CCC1A98000Q33646672-A50D9290-0A0B-4472-9039-8B1CDA65BF24Q33785383-91A96C23-25D8-4961-915B-2E85F97737E0Q33825265-54C57B34-3DD3-47FA-88CD-927042B0B8C2Q33843264-DD68DCA0-56B0-4FE6-817A-7D32870295AAQ33900276-D7D66EB3-8A1C-4673-8624-6CADE9D2A36FQ33964081-74994C00-BBC7-471F-A5F5-C9DDFC200EE2Q34002072-8983F981-0A4A-4A08-8670-C77DB1FF60B0Q34045548-FEC8E922-4436-4280-8A80-48A0C772DA63Q34070021-E18142F1-32B2-4EF2-96BB-BEE1A65906F2Q34231216-D0602BAF-BDC0-4843-AF42-E202C5664F25Q34280930-4DF74BE5-B1F2-4DB2-83D1-A1DE5C9F9E5FQ34344082-4E2146C1-3539-4739-A7C1-F6EB175AE905Q35195931-E99AF09F-B220-4B32-8CF3-DDB81776D311Q35530249-51E07CE0-8ADE-43F2-BD95-60F477296F57Q35634911-0F1B145B-01AD-4795-851D-D30C7AB52B46Q35842662-47499DB7-A00B-4093-8212-7A83CB889931Q35857548-350D0E9B-390F-42E1-ACC5-E1246C763F49Q35861970-4406E86D-3DC9-4FF7-96AA-12F5D9376999Q35868177-C73F15A1-A179-40CC-94EA-3A0ECCEA70AEQ35874803-7019FF5C-3B7E-4897-9E95-DB6737FFED25Q36308565-E359992B-E036-4158-AEC3-0501D518A683Q36380692-4A1C7CB2-9ED6-4F16-885D-44A1CDE6721DQ36397263-A88F68D5-2EB5-401C-8227-1781D06F81B9Q36438450-2F921C57-9745-4149-9C89-0669D3F74257Q36491901-960B9314-F334-449E-A068-E39FEB32ACD0Q36550140-1EB58F10-4772-4E23-9042-596BA3DEF4DAQ36689035-1E381277-1D89-4598-88E4-2FF4D8F52A23Q36821357-26BC9811-65C4-4FA4-BCE9-19482C4A923EQ36827430-BFC2CFC0-355E-42DE-99A5-B9F95DEAD7D8Q37062242-B012F42C-ABBF-4DB3-91B6-0EA42C7D44B6
P2860
DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
DNA-mediated immunization to t ...... s B viral infection in humans.
@ast
DNA-mediated immunization to t ...... s B viral infection in humans.
@en
DNA-mediated immunization to t ...... s B viral infection in humans.
@nl
type
label
DNA-mediated immunization to t ...... s B viral infection in humans.
@ast
DNA-mediated immunization to t ...... s B viral infection in humans.
@en
DNA-mediated immunization to t ...... s B viral infection in humans.
@nl
prefLabel
DNA-mediated immunization to t ...... s B viral infection in humans.
@ast
DNA-mediated immunization to t ...... s B viral infection in humans.
@en
DNA-mediated immunization to t ...... s B viral infection in humans.
@nl
P2093
P2860
P356
P1476
DNA-mediated immunization to t ...... s B viral infection in humans.
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.12.5307
P407
P577
1995-06-01T00:00:00Z